Mapping of serological testing and SARS-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020

Keyphrases

• European Countries 100%
• Serological Test 100%
• Seroprevalence Survey 100%
• SARS-CoV-2 Seroprevalence 100%
• Seroprevalence 80%
• Europe 60%
• COVID-19 40%
• Mitigation Strategies 40%
• Epidemiology 20%
• Healthcare Workers 20%
• Clinical Information 20%
• European Society 20%
• Serological Methods 20%
• Demographic Information 20%
• Laboratory Confirmed Cases 20%
• Diagnostic Purposes 20%
• Online Questionnaire 20%
• Limited Information 20%
• Commercial Test 20%
• Serology 20%
• IgG Response 20%
• Serological Assay 20%
• Pandemic Spread 20%
• Testing Approaches 20%
• Clinical Virology 20%
• Non-polio Enteroviruses 20%
• Convalescent Plasma 20%
• Lockdown 20%
• SARS-CoV-2 Pandemic 20%
• Mitigation Approaches 20%
• Network Member 20%
• SARS-CoV-2 Serology 20%
• First Pandemic Wave 20%
• Spike Antigen 20%

Medicine and Dentistry

• Seroprevalence 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Population 20%
• Diagnosis 20%
• Health Care 20%
• Cohort Effect 20%
• Clinical Virology 20%
• Poliomyelitis Virus 20%